A clinical study to evaluate the feasibility and dose delivery accuracy of modified track Dynamic WaveArc therapy
Completed
- Conditions
- Breast cancer (left), Spinal metastases
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Left breast cancer, post surgery. spinal metastases less than 3 lesions.
Exclusion Criteria
Severe complications. Mental illness. Re-irradiation. Dose distribution of DWA is inferior to conventional radiotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- single assignment
- Primary Outcome Measures
Name Time Method - Completion of treatment protocol
- Secondary Outcome Measures
Name Time Method acute adverse event rate 急性不良事件发生率
late adverse event rate 晚期不良事件发生率
recurrence-free survival in affected breast 受影响乳房的复发无生存期
deterioration of breast cosmetic outcomes rate 乳房美容效果恶化率
disease-free survival 无病生存期
overall survival 总生存期
local progression-free survival 局部无进展生存期
recurrence-free survival 复发无生存期
breast aggravation 乳房恶化
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Dynamic WaveArc therapy in treating left breast cancer and spinal metastases?
How does modified track Dynamic WaveArc therapy compare to standard radiation therapy in terms of dose delivery accuracy for breast cancer and spinal metastases?
Are there specific biomarkers that can predict patient response to modified track Dynamic WaveArc therapy in left breast cancer and spinal metastases?
What are the potential adverse events associated with modified track Dynamic WaveArc therapy and how can they be managed in cancer patients?
What are the current trends in radiation therapy for spinal metastases and left breast cancer, and how does this trial contribute to the field?